Literature DB >> 15348636

Skin sensitization study of two hydroxypropyl methylcellulose components (Benecel and E4M) of an injectable bone substitute in guinea pigs.

Y Amouriq1, X Bourges, P Weiss, J Bosco, J-M Bouler, G Daculsi.   

Abstract

Although initial results were promising for an injectable bone substitute (IBS) associating a hydroxypropyl methylcellulose (HPMC) polymer vector (Benecel, 2 w/w %) with biphasic calcium phosphate (BCP), a sensitization reaction occurred probably related to the degree of polymer purity. In this context, Benecel and another HPMC, E4M were investigated in the present study. The expected composition of the polymers was confirmed by gas-liquid chromatography. Studies in the guinea pig showed that Benecel has strong sensitization capacity and E4M none. Benecel manifests impurities (30 times more than E4M) in individual fibers or rounded clumps that are apparently responsible for extreme sensitization. Purification by ultracentrifugation associated with 0.2 microm filtration can decrease sensitization capacity considerably, though with a slight loss of polymer concentration. Fourier transform infrared (FTIR) analysis showed that the impurities were largely cellulose derivatives. However, extraction by organic solvent, followed by FTIR studies and micro-X analysis, detected an oily substance containing carbon and silicon associated with the cellulose derivatives. E4M, a polymer with no sensitization capacity, could replace Benecel and improve results with IBS.

Entities:  

Year:  2002        PMID: 15348636     DOI: 10.1023/a:1013873828079

Source DB:  PubMed          Journal:  J Mater Sci Mater Med        ISSN: 0957-4530            Impact factor:   3.896


  16 in total

1.  Macroporous biphasic calcium phosphate efficiency in mastoid cavity obliteration: experimental and clinical findings.

Authors:  G Daculsi; M Bagot d'Arc; P Corlieu; M Gersdorff
Journal:  Ann Otol Rhinol Laryngol       Date:  1992-08       Impact factor: 1.547

2.  Biphasic calcium phosphate/hydrosoluble polymer composites: a new concept for bone and dental substitution biomaterials.

Authors:  G Daculsi; P Weiss; J M Bouler; O Gauthier; F Millot; E Aguado
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

3.  Short-term effects of mineral particle sizes on cellular degradation activity after implantation of injectable calcium phosphate biomaterials and the consequences for bone substitution.

Authors:  O Gauthier; J M Bouler; P Weiss; J Bosco; E Aguado; G Daculsi
Journal:  Bone       Date:  1999-08       Impact factor: 4.398

4.  Validation of skin sensitization assays.

Authors:  D A Basketter; M Chamberlain
Journal:  Food Chem Toxicol       Date:  1995-12       Impact factor: 6.023

5.  In vitro evaluation of a new injectable calcium phosphate material.

Authors:  G Grimandi; P Weiss; F Millot; G Daculsi
Journal:  J Biomed Mater Res       Date:  1998-03-15

6.  The identification of contact allergens by animal assay. The guinea pig maximization test.

Authors:  B Magnusson; A M Kligman
Journal:  J Invest Dermatol       Date:  1969-03       Impact factor: 8.551

7.  Kinetic study of bone ingrowth and ceramic resorption associated with the implantation of different injectable calcium-phosphate bone substitutes.

Authors:  O Gauthier; J M Bouler; P Weiss; J Bosco; G Daculsi; E Aguado
Journal:  J Biomed Mater Res       Date:  1999-10

8.  Tissue biocompatibility of cellulose and its derivatives.

Authors:  T Miyamoto; S Takahashi; H Ito; H Inagaki; Y Noishiki
Journal:  J Biomed Mater Res       Date:  1989-01

9.  Biphasic calcium phosphate concept applied to artificial bone, implant coating and injectable bone substitute.

Authors:  G Daculsi
Journal:  Biomaterials       Date:  1998-08       Impact factor: 12.479

10.  Tissue response to biphasic calcium phosphate ceramic with different ratios of HA/beta TCP in periodontal osseous defects.

Authors:  E B Nery; R Z LeGeros; K L Lynch; K Lee
Journal:  J Periodontol       Date:  1992-09       Impact factor: 6.993

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.